Mylan, Teva set aside Provigil fight; Aurobindo expects FDA to lift ban; InnoPharma gets funds for generics;

@FiercePharma: India's Aurobindo hopes an FDA inspection this summer will lift import ban on antibiotics plant. More | Follow @FiercePharma

> FDA to again consider making hydrocodone combos class II drugs. More

> Missed forecast by Roche leads to Boniva shortage. News

> Novartis in tax fight over vaccine plant that HHS helped pay for. Story

> GSK extends $2.6 billion bid for Human Genome Sciences. Article

> InnoPharma has raised $8 million from Comerica Bank and NXT Capital Venture Finance to advance its work on niche generic and specialty pharmaceutical products in injectable and ophthalmic dosage forms. Release

> Genericsmaker Mylan ($MYL) has reached an agreement with Teva Pharmaceutical ($TEVA) over Teva's sleep drug Provigil that will allow Mylan to launch its generic Aug. 10, even before the 180 exclusivity period is finished. Story

> Indian drugmaker Aurobindo Pharma, which had some of its drugs banned from the U.S. since late 2010, says it expects the FDA to review its plant by September in anticipation of having the import ban lifted. Story

> Kentucky has won a $2.3 million settlement from Aventis in a case alleging that the company overcharged the state's Medicaid program. Story

Biotech News

@FierceBiotech: Check out this special report from @RyanMFierce: 5 next-gen software tools for biopharma R&D. Report | Follow @FierceBiotech

@RyanMFierce: Hi all, we're about to launch FierceBiotech's Fierce 15 biotech search. Countdown from 10... Survey | Follow @RyanMFierce

> Ohio-based Navidea Biopharmaceuticals has expanded to Andover, MA, north of Boston. Report

> Modulation Therapeutics has garnered a $500,000 award from The Multiple Myeloma Research Foundation as the company works on its lead drug candidate called MTI-101 for myeloma. Release

> Inclinix and PMG Research combine to boost trial enrollment business. Item

> Newton, MA, biotech Chiasma, a developer of oral peptide and protein drugs, has landed $3 million in debt financing. Report

Medical Device News

@FierceMedDev: Get your nominations in for the 15 fiercest private medical device developers while there is still time. Survey | Follow @FierceMedDev

> Pressure turns to Senate after House passes device tax repeal bill. Story

> Orthofix will cough up $42M to settle kickback case. News

> Open source coding could make medical devices safer. Article

> Edwards wins FDA nod to commence heart valve treatment tech clinical trial. More

And Finally... Drugmakers, dismayed over pricing reforms in Germany that they say place little value on new drugs, are asking the government to rethink its stance. Story